Klotho is advancing its ALS gene therapy candidate KLTO‑202 to the manufacturing phase, and is planning the first human ...

BrainStorm Cell Therapeutics issued a statement Tuesday supporting a Citizens’ Petition submitted to the FDA requesting the ...

Commonly prescribed medications for anxiety, depression and sleep disorders may be associated with a higher risk of ...

Brain-machine interfaces (BMIs) are becoming lifelines for people facing severe motor impairments. For many individuals with conditions like amyotrophic lateral sclerosis (ALS) or spinal cord injuries ...

JJ Potrikus, vice president of the New York Collegiate Baseball League, joined Bridge Street for details this morning along ...

The FDA granted orphan drug designation to Sineugene Therapeutics' SNUG01, a first-in-class experimental gene therapy for ...

On July 4, 1776, the Continental Congress adopted the Declaration of Independence, proclaiming U.S. independence from Britain ...

Tech billionaire Elon Musk’s Neuralink is one of the most talked about players in the BCI field, but the first product to ...

ALS is a slow progressing disease that doesn’t show symptoms right away. Dropping things often can be an early sign.

Unlike previous systems that convert brain signals into text, this BCI synthesizes actual speech almost instantaneously. The ...

The Food and Drug Administration has granted Fast Track designation to AMX0114 for the treatment of amyotrophic lateral sclerosis (ALS).

People from the punk and hardcore scenes who were on tour with Keil have remembered how kind he was. Scientists are finding new techniques to slow down the growth of amyotrophic lateral sclerosis (ALS ...